Norges Bank’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-449,400
| Closed | -$3.47M | – | 1830 |
|
|
2024
Q4 | $3.47M | Buy |
+449,400
| New | +$4.22M | ﹤0.01% | 1589 |
|
|
2024
Q3 | – | Sell |
-147,546
| Closed | -$1.73M | – | 1943 |
|
|
2024
Q2 | $1.73M | Sell |
147,546
-72,978
| -33% | -$1.14M | ﹤0.01% | 1744 |
|
|
2024
Q1 | $4.65M | Hold |
220,524
| – | – | ﹤0.01% | 1635 |
|
|
2023
Q4 | $3.96M | Sell |
220,524
-50,418
| -19% | -$888K | ﹤0.01% | 1716 |
|
|
2023
Q3 | $4.46M | Hold |
270,942
| – | – | ﹤0.01% | 1701 |
|
|
2023
Q2 | $5.42M | Hold |
270,942
| – | – | ﹤0.01% | 1700 |
|
|
2023
Q1 | $5.12M | Sell |
270,942
-55,676
| -17% | -$1.23M | ﹤0.01% | 1745 |
|
|
2022
Q4 | $7.41M | Hold |
326,618
| – | – | ﹤0.01% | 1654 |
|
|
2022
Q3 | $8.63M | Hold |
326,618
| – | – | ﹤0.01% | 1593 |
|
|
2022
Q2 | $8.07M | Sell |
326,618
-21,761
| -6% | -$544K | ﹤0.01% | 1640 |
|
|
2022
Q1 | $11.6M | Hold |
348,379
| – | – | ﹤0.01% | 1650 |
|
|
2021
Q4 | $11.4M | Buy |
348,379
+27,849
| +9% | +$948K | ﹤0.01% | 1722 |
|
|
2021
Q3 | $13.4M | Buy |
320,530
+6,967
| +2% | +$251K | ﹤0.01% | 1663 |
|
|
2021
Q2 | $12.2M | Sell |
313,563
-25,572
| -8% | -$915K | ﹤0.01% | 1719 |
|
|
2021
Q1 | $11.6M | Buy |
339,135
+4,278
| +1% | +$182K | ﹤0.01% | 1754 |
|
|
2020
Q4 | $15.2M | Buy |
334,857
+5,992
| +2% | +$209K | ﹤0.01% | 1650 |
|
|
2020
Q3 | $9.05M | Sell |
328,865
-26,513
| -7% | -$864K | ﹤0.01% | 1740 |
|
|
2020
Q2 | $13.1M | Sell |
355,378
-16,932
| -5% | -$631K | ﹤0.01% | 1640 |
|
|
2020
Q1 | $12.1M | Hold |
372,310
| – | – | ﹤0.01% | 1529 |
|
|
2019
Q4 | $15.3M | Hold |
372,310
| – | – | ﹤0.01% | 1665 |
|
|
2019
Q3 | $13.3M | Buy |
372,310
+37,041
| +11% | +$1.5M | ﹤0.01% | 1675 |
|
|
2019
Q2 | $17.2M | Buy |
335,269
+18,846
| +6% | +$941K | 0.01% | 1586 |
|
|
2019
Q1 | $18.1M | Buy |
316,423
+59,024
| +23% | +$2.92M | 0.01% | 1563 |
|
|
2018
Q4 | $10.8M | Buy |
257,399
+39,735
| +18% | +$2.33M | ﹤0.01% | 1710 |
|
|
2018
Q3 | $16.4M | Buy |
+217,664
| New | +$15.7M | 0.01% | 1622 |
|
|
2017
Q1 | – | Sell |
-44,943
| Closed | -$834K | – | 2174 |
|
|
2016
Q4 | $834K | Buy |
+44,943
| New | +$859K | ﹤0.01% | 2078 |
|
|
2016
Q3 | – | Sell |
-11,597
| Closed | -$93K | – | 2166 |
|
|
2016
Q2 | $93K | Sell |
11,597
-6,603
| -36% | -$73.3K | ﹤0.01% | 2167 |
|
|
2016
Q1 | $197K | Sell |
18,200
-1,800
| -9% | -$23K | ﹤0.01% | 2164 |
|
|
2015
Q4 | $332K | Hold |
20,000
| – | – | ﹤0.01% | 2196 |
|
|
2015
Q3 | $441K | Buy |
+20,000
| New | +$511K | ﹤0.01% | 2202 |
|
Other funds holding RGNX
RG
Norges Bank's RGNX Position: Q1 2025 in Review
Norges Bank sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 449,400 shares — an estimated $3.47M sold.
Norges Bank first reported a position in RGNX in Q3 2015 and held it in 30 quarters. The position peaked at $18.1M in Q1 2019. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.
- Norges Bank reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
- Norges Bank sold 449,400 Regenxbio shares in Q1 2025, an estimated $3.47M.
- Norges Bank first reported a position in Regenxbio in Q3 2015 and held it in 30 quarters.
- Norges Bank's Regenxbio position peaked at $18.1M in Q1 2019.
- 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.
Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.